首页> 美国卫生研究院文献>Clinical Molecular Pathology >Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis.
【2h】

Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis.

机译:酶联免疫吸附试验(ELISA)的开发用于检测囊性纤维化患者血清中的铜绿假单胞菌细胞表面抗原抗体。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An enzyme linked immunosorbent assay (ELISA) to measure free serum IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis was developed. Seven strains of P aeruginosa cells, treated with glutaraldehyde and representing the most commonly isolated serotypes in our cystic fibrosis unit, were used. The specificity of the test was confirmed by the absence of cross reacting antibodies to other Gram negative bacteria. The results showed differences in the titres of antibodies at different stages of P aeruginosa infection. Because of its reproducibility, specificity, and sensitivity these preliminary results suggest that this test may be of value in monitoring the progress of P aeruginosa infection in patients with cystic fibrosis.
机译:开发了一种酶联免疫吸附测定法(ELISA),用于测定囊性纤维化患者中铜绿假单胞菌的游离血清IgG抗体。使用了七种经戊二醛处理的铜绿假单胞菌细胞株,它们代表了我们囊性纤维化病房中最常见的血清型。通过不存在与其他革兰氏阴性细菌的交叉反应抗体来确认测试的特异性。结果显示在铜绿假单胞菌感染的不同阶段,抗体的效价存在差异。由于其可再现性,特异性和敏感性,这些初步结果表明,该测试对于监测囊性纤维化患者的铜绿假单胞菌感染的进展可能具有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号